Your browser doesn't support javascript.
loading
French college of gynecologists and obstetricians (CNGOF) recommendations for clinical practice: Place of breast self-examination in screening strategies.
Lavoue, Vincent; Favier, Amélia; Franck, Sophie; Boutet, Gérard; Azuar, Anne-Sophie; Brousse, Susie; Golfier, François; Uzan, Catherine; Vaysse, Charlotte; Molière, Sébastien; Boisserie-Lacroix, Martine; Kermarrec, Edith; Seror, Jean-Yves; Delpech, Yann; Luporsi, Élisabeth; Maugard, Christine M; Taris, Nicolas; Chabbert-Buffet, Nathalie; Sabah, Jonathan; Alghamdi, Khalid; Fritel, Xavier; Mathelin, Carole.
Afiliación
  • Lavoue V; CHU Service de Gynécologie, 16 Boulevard de Bulgarie, 35200, Rennes, France.
  • Favier A; Gynécologie-obstétrique et Médecine de La Reproduction, Maternité Hôpital Tenon, 4 Rue de La Chine, 75020, Paris, France.
  • Franck S; Institut Curie, 26 Rue D'Ulm, 75248, Paris Cedex 05, France.
  • Boutet G; AGREGA, Service de Chirurgie Gynécologique et Médecine de La Reproduction, Centre Aliénor D'Aquitaine, Centre Hospitalier Universitaire de Bordeaux, Groupe Hospitalier Pellegrin, Place Amélie-Raba-Léon, 33000, Bordeaux, France.
  • Azuar AS; Centre Hospitalier Clavary, Chemin de Clavary, 06130, Grasse, France.
  • Brousse S; Service D'oncologie Chirurgicale, Centre Eugène Marquis, Unicancer, Rennes, France.
  • Golfier F; Service de Chirurgie Gynécologique et Cancérologique - Obstétrique, Hospices Civils de Lyon, CHU Lyon Sud, Lyon, France.
  • Uzan C; Hôpital Pitié Salpetrière, 47 Bld de L'Hôpital, 75013, Paris, France.
  • Vaysse C; Service de Chirurgie Oncologique, CHU Toulouse, Institut Universitaire Du Cancer de Toulouse-Oncopole, 1 Avenue Irène Joliot Curie, 31059, Toulouse, France.
  • Molière S; Imagerie Du Sein, CHRU, Avenue Molière, 67200, Strasbourg, France.
  • Boisserie-Lacroix M; Unité de Radiologie-sénologie. Institut Bergonié, 229 Cours de L'Argonne, 33000, Bordeaux, France.
  • Kermarrec E; Hôpital Tenon Service de Radiologie, 4 Rue de La Chine, 75020, Paris, France.
  • Seror JY; Imagerie Duroc, 9 Ter Boulevard Montparnasse 75006 Paris, France.
  • Delpech Y; Centre Antoine Lacassagne, 33 Avenue de Valombrose, 06189, Nice, France.
  • Luporsi É; Oncologie Médicale et Oncogénétique, CHR Metz-Thionville, Hôpital de Mercy, 1 Allée Du Château, 57085, Metz, France.
  • Maugard CM; Service de Génétique Oncologique Clinique et Unité de Génétique Oncologique Moléculaire, Hôpitaux Universitaires de Strasbourg, 1 Avenue Molière, 67200, Strasbourg, France.
  • Taris N; Service de Génétique Oncologique, ICANS, 17 Rue Calmette, 67200, Strasbourg, France, France.
  • Chabbert-Buffet N; Hôpital Tenon Service de Gynécologie-obstétrique, 4 Rue de La Chine, 75020, Paris, France.
  • Sabah J; CHRU Avenue Molière, 67200, Strasbourg et ICANS, 17 Rue Albert Calmette, 67033, Strasbourg,Cedex, France.
  • Alghamdi K; CHRU Avenue Molière, 67200, Strasbourg et ICANS, 17 Rue Albert Calmette, 67033, Strasbourg,Cedex, France.
  • Fritel X; Centre Hospitalo-universitaire de Poitiers, 2 Rue de La Milétrie, 86021, Poitiers, France.
  • Mathelin C; CHRU Avenue Molière, 67200, Strasbourg et ICANS, 17 Rue Albert Calmette, 67033, Strasbourg,Cedex, France. Electronic address: c.mathelin@icans.eu.
Breast ; 75: 103619, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38547580
ABSTRACT
Breast cancer is the most common female cancer in the world. Numerous studies have shown that the risk of metastatic disease increases with tumor volume. In this context, it is useful to assess whether the regular practice of formal breast self-examination (BSE) as opposed to breast awareness has an impact on the number of cancers diagnosed, their stage, the treatments used and mortality.

DESIGN:

The Commission of Senology (CS) of the Collège National de Gynécologie et Obstétrique Français (CNGOF) respected and followed the Grading of Recommendations Assessment, Development and Evaluation method to assess the quality of the evidence on which the recommendations were based.

METHODS:

The CS studied 16 questions individualizing four groups of women (general population, women aged over 75, high-risk women, and women previously treated for breast cancer). For each situation, it was determined whether the practice of BSE versus abstention from this examination led to detection of more breast cancers and/or recurrences and/or reduced treatment and/or increased survival.

RESULTS:

BSE should not be recommended for women in the general population, who otherwise benefit from clinical breast examination by practitioners from the age of 25, and from organized screening from 50 to 74 (strong recommendation). In the absence of data on the benefits of BSE in patients aged over 75, for those at high risk and those previously treated for breast cancer, the CS was unable to issue recommendations. Thus, if women in these categories wish to undergo BSE, information on the benefits and risks observed in the general population must be given, notably that BSE is associated with a higher number of referrals, biopsies, and a reduced quality of life.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Autoexamen de Mamas / Detección Precoz del Cáncer Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Breast Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Autoexamen de Mamas / Detección Precoz del Cáncer Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Breast Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Francia